BSX vs SYK · P/E 20, rev $20.07B vs P/E 35, rev $6.59B
Boston Scientific Corp (BSX) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the BSX and SYK stock pages for the full models.
Not investment advice.